Fundz

Arrivent Biopharma Closes $155 Million Oversubscribed Series B Financing

PUBLIC · AVBPMar 27, 2023

Amount Raised

$155 Million

Round Type

Series B

Newtown SquareBiotechnology

Description

ArriVent Biopharma, Inc., dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the completion of a $155 million oversubscribed Series B financing. The proceeds will be used to support pivotal Phase 3 and additional studies with the Company’s lead product candidate furmonertinib

Quick answer

ArriVent raised $155 Million in a Series B round, dated March 27, 2023. ArriVent is based in Newtown Square, Pennsylvania, United States.

How much did ArriVent raise?
ArriVent raised $155 Million in a Series B round on March 27, 2023.
What does ArriVent do?
ArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products.
Where is ArriVent based and how big is it?
ArriVent is based in Newtown Square, Pennsylvania, United States. Fundz records about 52 employees.
Who are the decision-makers at ArriVent?
Fundz holds 1 contact at ArriVent, including the Vice President of Commercial Operations. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as ArriVent that raised within 45 days of this round, from Fundz verified event records.

  • Decoy Therapeutics Inc. raised $6M on May 11, 2023.
  • Satellos Bioscience raised $33M on May 10, 2023.
  • Werewool raised $3.7M (Seed) on May 10, 2023.
  • Orgenesis Inc. raised $5M on May 10, 2023.
  • Quanta Therapeutics raised $51M on May 10, 2023.
  • Interface Polymers raised an undisclosed amount (Funding Round) on May 9, 2023.

Who to call at ArriVent, and when

A new round usually means ArriVent is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ArriVent raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ArriVent, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ArriVent. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ArriVent

Location

Newtown Square, Pennsylvania, United States

About

ArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products. With a deep and global network, ArriVent seeks to access unique and best-in-class drug candidates at various development stages, including those coming from China and other emerging biotech hubs. Through strategic collaborations with innovative biopharma companies, ArriVent aims to globalize medicines for patients with unmet medical need in a broad range of diseases, with an initial focus in oncology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ArriVent raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsHenning T., Vice President of Commercial Operations hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ArriVent's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

ArriVent raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.